Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 11-2011 | 09-2011 | 08-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 1,512 | N/A | 1,529 | 0 |
| Marketable Securities | N/A | 2,185 | N/A | 2,186 | 0 |
| Receivables | N/A | 150 | 560 | 567 | 0 |
| Other current assets | 0 | 0 | 2 | 0 | 0 |
| TOTAL | $N/A | $3,866 | $562 | $4,284 | $0 |
| Non-Current Assets | |||||
| PPE Net | N/A | 11 | 20 | 17 | N/A |
| Investments And Advances | 0 | 0 | 0 | 10 | 0 |
| Other Non-Current Assets | 0 | 15 | 0 | 14 | 0 |
| TOTAL | $N/A | $26 | $20 | $42 | $N/A |
| Total Assets | $N/A | $3,903 | $582 | $4,326 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 424 | 0 | 441 | 0 |
| TOTAL | $N/A | $424 | $N/A | $441 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 161 | 0 | 161 | 0 |
| TOTAL | $N/A | $161 | $N/A | $161 | $N/A |
| Total Liabilities | $N/A | $585 | $N/A | $602 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 70,188 | N/A | N/A | N/A |
| Common Shares | N/A | 70 | N/A | 70 | 0 |
| Retained earnings | N/A | -15,026 | N/A | -14,547 | 0 |
| Other shareholders' equity | 0 | -4 | 0 | 0 | 0 |
| TOTAL | $N/A | $3,317 | $N/A | $3,724 | $0 |
| Total Liabilities And Equity | $0 | $3,903 | $0 | $4,326 | $0 |